Clinical Trial Update: Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating airway hyper-responsiveness in asthma using a salmeterol/fluticasone propionate combination has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Salmeterol/Fluticasone Propionate combination product (salmeterol and fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED